Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.82% ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.

Nasdaq has announced that Michael Saylor’s company, MicroStrategy, will have its stock (MSTR) added to the Nasdaq-100 Index, ...

Engineers have developed a lipid nanoparticle (LNP) that delivers mRNA therapeutic to the placenta to treat pre-eclampsia in mice with human trials on the horizon.

check out more Market Domination Overtime here. This post was written by Naomi Buchanan. Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim ...

Penn Engineers have developed a Lipid Nanoparticle (LNP) that delivers mRNA theraputic to the placenta to treat pre-eclampsia ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Rea Moderna (MRNA) shares tumble after ...